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Computer modeling of molecular signaling cascades can provide useful insight into the 
underlying complexities of biological systems. We present a refined approach for the 
discrete modeling of protein interactions within the environment of a single cell. The 
technique we offer utilizes the Membrane Systems paradigm which, due to its hierar-
chical structure, lends itself readily to mimic the behavior of cells. Since our approach 
is nondeterministic and discrete, it provides an interesting contrast to the standard de-
terministic ordinary differential equations techniques. We argue that our approach may 
outperform ordinary differential equations when modeling systems with relatively low 
numbers of molecules - a frequent occurrence in cellular signaling cascades. 
Refinements over our previous modeling efforts include the addition of nondetermin-
ism for handling reaction competition over limited reactants, increased efficiency in the 
storing and sorting of reaction waiting times, and modifications of the model reactions. 
Results of our discrete simulation of the type I and type II Fas-mediated apoptotic sig-
naling cascade are illustrated and compared with two approaches: one based on ordinary 
differential equations and another based on the well-known Gillespie algorithm. 
Keywords: Signal transduction pathway; simulation of pathways; Membrane Systems; 
ODE; discrete simulation; nondeterministic simulation. 
1. Introduction 
Cellular apoptosis, or programmed cell death, is an important process in biological 
systems. It is an effective method for the elimination of unwanted or damaged cells 
in an organism. Kerr labeled apoptosis as being distinct from necrotic 
cell death, citing a lack of inflammation of the tissue among other differences. The 
study of apoptotic signaling cascades is especially interesting to the fields of biology 
and medicine since defects in apoptotic signaling has been linked to cancer and 
various autoimmune disorders. 
In the past decade, there has been a wealth of information discovered on the 
Fas-mediated apoptotic pathway. Deviations from normal cellular activity induced 
by the human immunodeficiency virus including suppression of 
Fas-mediated apoptosis in HIV-infected CD4+ T cells and the death of healthy, 
uninfected 'bystander' cells . Besides autoimmune disorders, cancerous cells have 
been shown to be resistant to Fas-induced apoptosis [1]. Because many of the 
proteins involved in this pathway have been identified, it is an ideal candidate to 
illustrate the effectiveness of our modeling technique. We hope to use our simulator 
to provide a deeper understanding of the subtleties behind Fas signal transduction. 
In this paper, we provide the framework for our discrete nondeterministic model-
ing method: a Membrane Systems approach. Our Nondeterministic Waiting Time 
(NWT) algorithm is a refined version of our previous modeling efforts Section 
2 provides the refinements to our previous Membrane System approach. Section 3 
presents a full description of our algorithm. In Section 4, we provide results from ap-
plying our algorithm to a small signaling cascade with low molecular multiplicities, 
illuminating the differences in results obtained by our approach and an ordinary 
differential equations simulation technique. Results from our simulation of the Fas 
pathway are given in Section 5. Section 6 contains a discussion on future avenues 
of research. 
N.B., we will use the words rule and reaction interchangeably throughout this 
paper. In the context of Membrane Systems, we have rules associated with sym-
bols, whereas in the context of the cell we have reactions associated with pro-
teins/molecules. 
2. Refinements On Previous Work 
we described a discrete approach for simulating molecular signal cascades 
which employs the Membrane Systems paradigm. We also provided some prelim-
inary results on Fas pathway simulation. Here we provide a simulation technique 
which is more robust and efficient than our previous effort. The claim of robust-
ness is satisfied by the addition of nondeterminism, and efficiency by implementing 
a nonstandard heap to sort the reactions. Since our approach is nondeterministic 
and discrete, we believe it can offer a unique perspective on molecular signaling 
cascades. Hence, we argue that our algorithm is more advantageous than standard 
modeling techniques involving ordinary differential equations. 
The advantage is understood when one considers reaction competition over lim-
ited reactants - that is, a situation where two or more reactions are attempting 
to simultaneously use reactants of low molecular multiplicity. Ordinary differential 
equations are appropriate when one seeks the average behavior of systems involv-
ing large populations - e.g., modeling dynamics of large cell populations over time. 
However, molecular signaling cascades can often involve very low molecular multi-
plicities - e.g., the ~ 700 molecules of Vpr [2] affecting apoptosis in HIV infection 
Using ordinary differential equations to model these situations may be mislead-
ing. We will clarify the difference between discrete and continuous modeling in the 
following example: 
Assume we have two different reactions competing over a single molecule. An 
ODE method will allow both reactions to be applied, borrowing a fraction of each 
molecule to satisfy each equation. In contrast, our discrete approach maintains 
molecular integrity. Our NWT algorithm allows the single molecule to satisfy only 
one of the two reactions (nondeterministically chosen), thus sending the biological 
system on a different evolutionary path than that of the ODE simulation. The 
aggregate effects of these nondeterministic decisions over time, could lead to inter-
esting results describing the molecular behavior of a cell. 
Our second improvement, using a specialized heap to store reactions, allows 
the NWT algorithm to be computationally competitive with ordinary differential 
equations methods. Our algorithm employs a heap, but with two nonstandard 
properties: 
(i) once initialized, the heap does not grow or shrink; 
(ii) multiple nodes throughout the heap must be updated simultaneously (during 
the same update step of the heap). 
The implementation of a priority queue for sorting values associated with reac-
tions has its roots which we will elaborate on further during the description 
of our algorithm in the next section. By storing reactions in this way, our meso-
scopic approach has an execution time similar to the generally faster macroscopic 
approaches - techniques using ODEs. 
Additionally, we have made improvements to the Fas model 
Incorporating these model refinements allows us to 
compare our discrete simulator and the continuous ODE technique provided in [9]. 
3. Our Membrane Systems Approach 
We will now provide the reader with a brief description of our proposed modeling 
technique, followed by a statement of the algorithm and a discussion on its main 
ideas. 
3.1. Description of technique 
We have designed a Membrane System which tracks the changes of molecular multi-
plicities over time. The evolution of the system is led by the simulation of individual 
chemical reactions that are asynchronous and occur over variable lengths of time. 
The amount of time required for a given reaction to occur is governed by the number 
of the reactants present in the system. In this way, our simulator obeys the Law of 
Mass Action - reaction rate depends proportionally on reactant multiplicities. 
The driving force behind our simulator is the reaction Waiting Time (WT). 
Throughout the entire simulation run, each reaction has a WT associated to it. 
The WT informs the simulator the next instant a reaction is slotted to occur. We 
will first describe the mathematics behind WT calculation, then provide an example 
to help clarify how the calculation is used. 
To each reaction (R), there is an associated kinetic rate constant (UR). These 
kinetic rate constants are provided in the literature with units based on concentra-
tions, which are required for an ODE-based simulation. The units for these kinetics 
rate constants are s _ 1 for first order reactions, nM~1s~1 for second order reactions 
and nM~1nM~1s~1 for third order reactions. Since our simulator employs indi-
vidual molecules, we need to convert these constants into a suitable form, based 
on multiplicities instead of concentrations. Our simulator uses the kinetic rate con-
stant to compute an appropriate kinetic constant per reaction (constR) according 
to the following equation: 
constR =
 Tr. . ——r (1) 
V'-1 x N*-1 v ' 
where V is the volume of the system, N is Avogadro's constant (6.0221415 x 1023) 
and i is the number of reactants involved in the reaction. 
During initialization, the kinetic constant (constR) is calculated and stored for 
every reaction in the model. For all the simulations described in this paper, we 
assume the volume is constant. Thus, the kinetic constant for any reaction is 
indeed a constant. Using this kinetic constant and the molecular multiplicities of 
the system, the simulator calculates the initial WT for every reaction. For a second 
order reaction, the calculation of WT is as follows: 
WtR
 ~ constR * \A\ * \B\ *- ' 
where A and B are the two reactants required for reaction R, and \A\ and \B\ are 
the number of molecules present in the system at the moment of WT calculation. 
Waiting time calculations for first or third order reactions are similar, having one 
or three reactants, respectively. 
Suppose a reaction (-R1) has a waiting time of five seconds. The simulator will 
apply Rl exactly once at time t + 5 , where t represents the simulation time when the 
WT was calculated. After Rl is applied, the number of reactants for it has changed, 
so its WT is recalculated. Additionally, the WT for all reactions using products or 
reactants of Rl must be recalculated, since the multiplicities have changed. 
3.2. Nondeterministic Waiting Time (NWT) algorithm 
We present our algorithm below: 
1. Initialization: Read information on pathway (SBML code). Compute the 
kinetic constant (constR) and initial WT for all reactions in the system. Build 
a min-heap of reactions (sorted by the WT). Set simulation time to zero 
(t = 0). 
2. Select Rule: Select the reaction with the lowest WT. If there is a tie, go to 
step 3. If not, proceed to step 4. 
3. Handle Tie: If there are enough reactants available to satisfy all reactions 
in the tie, execute all the tied reactions in step 4. If there are not enough 
reactants to accommodate all the tied reactions, nondeterministically apply 
reactions until reactant supply is exhausted. 
4. Apply Rule: Update the multiplicities of the reactants and products involved 
in the reaction(s) from step 2. Aggregate the simulation time (t = t+WT). 
5. Update Rules and Maintain Heap: Recalculate the WT for any reactions 
whose reactants include a reactant or product of the applied reaction(s). For 
each such reaction compare the new WT with the existing WT and keep 
the smallest of the two values. After WT calculation, ensure the min-heap 
property is maintained around each recalculated node. 
6. Check Done: If the desired simulation time has not been reached, go back 
to step 2. 
Step one, the initialization phase, is run only once during execution. During 
this step, we establish an array of reactions and build a min-heap with the standard 
bottom-up approach (sorted by WTs). Step two, selecting a rule, can be accom-
plished in constant time, since we merely access the top node of the heap - the 
first index of the array. Determining if there is a tie for minimum waiting time is 
accomplished simply by recursively checking the children of a tied node (starting 
with the head node). Since ties are relatively infrequent and small in the number of 
reactions involved, the recursion is not computationally or memory intensive. Given 
a tie, it is computationally inexpensive to check if there is a sufficient number of 
reactants by initializing a reactant list in each reaction node pointing to current 
multiplicity. 
When reactions are involved in a tie, pointers to the reaction nodes are placed 
in a temporary array. Therefore, nondeterministically applying as many rules as 
possible consists of generating random integers from 1 to x, where x is the number 
of reactions in the temporary array, and attempting to apply (if sufficient reactants 
exist) the rule whose index is randomly chosen. Whether a rule is applied or not 
- insufficient reactants - it is removed from the temporary array until there are no 
reactions left to apply. 
After applying the reaction(s), we must recalculate all reactions affected by the 
multiplicity changes of the system. Some reactions will end up with a new WT, 
which could be smaller than the previous one; thus they may need to be repositioned 
in the heap. Therefore, as we recalculate each WT in step five, we must perform 
some heap maintenance. 
In order to efficiently handle the dynamics of the reaction waiting times during 
a simulation run, we proceed with updating the heap in a nonstandard manner. 
Gibson and Bruck described a method for updating a priority queue containing 
the stochastic values of their Gillespie Algorithm adaptation. we 
define the following functions for our heap implementation: 
• Swap(A,B): Exchange the positions of reactions A and B in the heap. 
• BuildHeap(): Establish the min-heap property, based on reaction WT. 
(Bottom-up technique). 
• UpdateHeap(A): Upon recalculation of the WT for reaction A, ensure that 
the min-heap property is satisfied regarding A - i.e., the parent and children 
(if they exist) of A are not in violation of the min-heap property. 
Each node in the heap contains all the information for a particular reaction 
including: (a) the simulation time for the next execution of the reaction (t+WT, 
where t is the simulation time when the WT was last calculated), (b) the kinetic 
constant (constn) for calculation of WT, (c) an array pointing to the reactants and 
one pointing to the products, telling the simulator what multiplicities to update 
when the reaction is applied, (d) index of the reaction in the heap. 
As we stated earlier, the heap is initially built with a bottom-up approach. 
However, the maintenance of our heap is accomplished in a nonstandard way. The 
heap does not grow or shrink during the simulation run because we begin and end 
with the same number of reactions. When a reaction is applied and its WT is 
recalculated, the new WT is often very close to the old one - a consequence of the 
stoichiometry of biological systems. Therefore, the applied rule will frequently end 
up near the top of the heap after WT recalculation and heap maintenance. Because 
of this, we do not remove the top node of the heap when applying a rule. Instead, we 
leave the node at the top of the heap and, upon recalculation of the WT, bubble the 
node down as needed. Additionally, when we recalculate the rules affected by the 
multiplicity changes from an applied rule, we leave the nodes in place and bubble 
up or down as necessary until the min-heap property is satisfied. 
The standard heap approach, where the top nodes are removed after being ap-
plied and new nodes are added to the bottom and bubbled up, requires log(r) 
resorting time, where r is the total number of reactions. As a consequence of the 
kinetics of signaling cascades, an increase or decrease of one molecule for the reac-
tants does not drastically change the WT of a reaction. Therefore, our UpdateHeap 
method can accomplish the resort in log(r'), where r' is a number much smaller 
than r. Moreover, the node will not move very far up or down the heap each time 
the UpdateHeap method is called. 
There are bounds on the number of calls to the UpdateHeap method. To clarify, 
we provide several assumptions about signaling cascades which are often valid: 
1. Each reaction involves at most six distinct proteins in the pathway considered. 
2. The number of reactions having the same reactant is at most five (but usually 
three). 
3. Due to the variety of molecular multiplicities and reaction rates, there are not 
many reactions occurring at the same instant. 
Our previous algorithm had a runtime of 0(n2 logn). However, based on this 
new heap implementation and the assumptions listed above, our new algorithm has 
a runtime of O(nlogn). The previous algorithm was capable of simulating eight 
hours of Fas signal transduction in thirty to forty minutes. The modified approach 
presented in this paper completes the same simulation in three to four minutes. 
4. Example of Nondeterminism 
In the interest of understanding the behavior of our NWT algorithm in contrast 
to a deterministic ordinary differential equations method, we have designed a small 
signaling cascade (see Fig. 1). In this model, ml and m3 competitively bind to ml. 
The ml protein attempts to activate ml, which leads to the upregulation of mA. 
The m3 protein acts as an inhibitor to the upregulation of m4, through binding and 
inhibition of m2 activation. 
Although this is a simplified model, designed to illustrate the nondeterminism 
of our algorithm, the role of m2 is similar to the transactivator protein of HIV, Tat, 
which regulates the viral gene expression. Tat has been shown to increase HIV gene 
expression by 200-fold [10]. Without the increased transcription rate, the infected 
cell can not create new virions. 
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Fig. 1. An example signaling cascade. Here m l and m3 competitively bind to ml. When ml 
binds to m2, the result is the activation of ml. After activation, m2* proceeds to upregulate mA 
expression. The m3 protein acts as an inhibitor for the upregulation of mA, since it binds to m2 
and prevents its activation. 
We translated the reactions depicted in Fig. 1 into a system of ordinary differ-
ential equations 
d[ml] 
dt 
d[m2] 
dt 
d[m3] 
dt 
d[ml : m2] 
dt 
d[m3 : m2] 
dt 
d[m2*} 
dt 
d[mA\ 
dt 
= — k\ [ml][m2] + k^[ml : m2] 
= -k\ [ml] [ra2] - k\ [m3] [ra2] + k2 [m2mRNA\ 
= —ki[m3][m2] + ks[m3 : m2] 
= fci[ml][m2] — ^ [ m l : m2] 
= k\ [m3] [m2] — fc3 [m3 : m2] 
= ks[ml : m2] 
= kA[m2*][mAmRN A] (3) 
with the following kinetic rate constants: 
Kinetic Rates 
fci 
k2 
ks 
k^ 
0.001s-1 
0.1s-1 
We coded the system of ordinary differential equations (3) in MATLAB and 
solved them using the ode45 method provided by the software. The model was also 
encoded into SBML, using the CellDesigner software v3.5.1 [18]. The SBML code 
was used to initialize our simulator. 
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Fig. 2. The graph clearly shows the distinct evolutionary paths of the three seperate NWT 
simulation runs (red, blue and cyan). The nondeterniinistic results are significantly distinct from 
the deterministic ODE method (black). 
Results of three nondeterministic simulations are provided in Fig. 2 as well as 
the deterministic results of the ODE simulation. The ramifications of our nonde-
terministic approach are clear, as each run resulted in different multiplicities of m4. 
The ODE simulation, allowing the use of fractional molecules, continuously allowed 
ml to bind to m2 throughout the entire run. In contrast, our simulator accurately 
depicted the competition between ml and m3 for the binding of the low number of 
m2 molecules. 
The above example is used to illuminate the difference between our NWT al-
gorithm and an ordinary differential equations method. In the next section, we 
provide a comparative analysis between our approach and an ODE approach for 
simulation of the Fas-mediated apoptotic pathway 
5. The Fas-mediated Apoptotic Pathway 
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Fig. 3. Picture of the Fas-mediated apoptotic signal cascade. The pathway begins with the Fas 
ligand binding to the receptor site on the cell surface, and ends with the cleavage of Caspase-
3 into active form. Both the type I and type II pathways are seen here. The former shows 
Caspase-8* directly cleaving Caspase-3, while the latter requires amplification of signal through 
the mitochondria. 
The pathway is illustrated in Fig. 3, and we provide the following description of 
the signal cascade 
The pathway begins when a ligand, FasL, binds to a transmembrane recep-
tor, Fas. When this occurs, a conformational change takes place in the receptor 
producing the complex Fasc. The cytoplasmic domain of this complex recruits Fas-
associated death domain (FADD), with a maximum of three FADD per binding 
site (trimer). While FADD is bound to the complex Fasc, Caspase-8 and Flip are 
recruited competitively. Once at least two molecules of Caspase-8 have been re-
cruited to a binding site, a dimer, Caspas-8241, is released into the cytoplasm, and 
is then phosphorylated into active form (Caspase-8*). The binding of FLIP to the 
Fasc complex is considered to be an inhibitor of apoptosis, because it decreases the 
number of sites available for Caspase-8 recruitment. 
Unless sufficiently inhibited, the signaling cascade can continue in two different 
ways - the type I or type II pathway. If the initial concentration of Caspase-8 is large 
enough, Caspase-3 will be directly phosphorylated by the Caspase-8* (the type I 
pathway). Otherwise, Caspase-8* can truncate molecules of Bid (tBid). Each tBid 
molecule binds with two Bax molecules, which leads to the release of Cytochrome 
c from the mitochondria (type II pathway). Once released, Cytochrome c binds to 
Apaf and ATP, forming a complex that can recruit and phosphorylate Caspase-9 
(Caspase-9*). Caspase-9* continues the cascade through the phosphorylation of 
Caspase-3. We consider the activation of Caspase-3 to be the end of the signaling 
cascade. Hence, the cell is dead once all of the Caspase-3 molecules are activated. 
Besides Flip, there are other inhibiting factors at play: Bcl-2 hinders the release 
of Cytochrome c from the mitochondria and XIAP blocks Caspase-9* from binding 
with Caspase-3. In other words, if sufficient levels of FLIP, Bcl-2, and/or XIAP 
exist, the apoptotic pathway can be blocked, and the cell lives. 
The pathway described above was modeled with 101 different rules working on 
53 distinct proteins and protein complexes. Fei Hua et al., in [9], provided the 
results of an ODE simulation, as well as some experimental data (from the Jurkat 
cell line) which they used to fit their model. We compared our results with the 
results from [9], simulating the same 101 rules and same initial conditions as the 
ODE simulation. 
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Fig. 4. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]). The two graphs show the decline over time of full length Caspase-3, which means 
there is an increase in active Caspase-3. At baseline Bcl-2 concentration, full length Caspase-3 
approaches zero approximately four hours into the simulation. However, apoptosis is signficantly 
inhibited as Bcl-2 levels are increased by 10-fold and 100-fold. 
5.1. Results of discrete method 
we simulated three different initial concentrations of Bcl-2: the base-
line value (75nMs), an increase by 10-fold (750nMs), and an increase by 100-fold 
(7500nMs). Assuming a cell volume of 10~12 liters, we converted the concentra-
tions into molecular multiplicities: baseline value (45166 molecules), 10-fold (451660 
molecules), and 100-fold (4516606 molecules). We expected to see a decline in 
Caspase-3 activation as Bcl-2 concentration was increased by 10-fold and 100-fold; 
we provide the results of our simulations in (Fig. 4). We also provide the results 
of simulations with a decrease of 10-fold and 100-fold in comparison to the baseline 
Bcl-2 multiplicity (Fig. 5). Notice, the graphs based on our Membrane System 
simulations are comparable to the ODE results from [9]. 
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5. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]. These results illustrate how the type I pathway is insensitive to decreases of Bcl-2 
concentrations by 10-fold and 100-fold. We see agreement between the two different simulators. 
5.2. Bcl-2's effects on the Type II pathway 
Next, we analyzed the Caspase-3 activation kinetics by considering different mech-
anisms through which Bcl-2 can block the type II pathway. In [16], [14], and [3] the 
authors suggested that Bcl-2 might bind with (a) Bax, (b) Bid, (c) tBid, or (d) both 
Bax and tBid to block the mitochondrial pathway. We implemented four different 
sets of rules to test each Bcl-2 binding mechanisms. We refer the interested reader 
to [9] for the details of the rules. 
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Fig. 6. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]). Here we see the effects of Bcl-2 binding to Bax only. It seems that Bcl-2 binding 
only with Bax is the second most effective method for blocking the apoptotic pathway. 
The dynamics of Caspase-3 activation were studied by increasing the baseline 
Bcl-2 concentration by 10-fold and 100-fold. The conclusion of [9] is that Bcl-2 
binding to both Bax and tBid (d) is the most efficient mechanism for inhibiting 
apoptosis. Our Membrane System agrees with the observations The 
results of (d) are illustrated in Fig. 4, and (a) - (c) can be seen in Fig. 6 - Fig. 8. 
A comparison of (a) - (d) at baseline Bcl-2 concentration is shown in Fig. 9. 
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Fig. 7. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]). These two graphs show Bcl-2 binding to tBid only. We see considerably less 
inhibition of the pathway in this mechanism. The release of Cytochrome c is contingent on the 
binding of one tBid to two Bax molecules, and thus, blocking Bax would be more effective than 
blocking tBid. 
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Fig. 8. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]). There is very little change in apoptotic behavior when Bcl-2 is allowed to bind 
only with Bid. This is because Bcl-2 binding to Bid is a reversible reaction, and once Bid is 
truncated to tBid, it is no longer available to bind with Bcl-2. 
5.3. Modeling the behavior of the Type I pathway 
Some cells are not sensitive to Bcl-2 over expression, as described In these 
cells, Caspase-3 is activated through the type I pathway, bypassing the role of the 
mitochondria and Bcl-2. Scaffidi et al. have suggested in that the type of path-
way is chosen based on the concentration of Caspase-8 generated in active form 
following the binding of Fas ligand to its receptor site. High concentration of active 
Caspase-8 allows for direct activation of Caspase-3 (type I), but if the concentra-
tion of Caspase-8 is sufficiently low, amplification of the death signal through the 
mitochondria is required to induce cell death (type II). We tested this hypothesis 
by increasing the initial concentration of Caspase-8 by 20-fold (from 33.33nMs to 
666.6nMs), which was expected to lead to increased active Caspase-8 throughout 
the simulation run. 
We ran two different version of the increased Caspase-8 model, using the baseline 
concentration of Bcl-2 and an increase of Bcl-2 by 100-fold, in order to gauge the 
sensitivity of the type I pathway to Bcl-2 upregulation. Fig. 10 shows that Caspase-
3 activation was not sensitive to the increase in Bcl-2 concentration, which is the 
hallmark for type I pathway dominant behavior. N.B., for these simulations Bcl-2 
was allowed to bind to both Bax and tBid, which was shown above to be the most 
efficient mechanism for Bcl-2 inhibition of apoptosis. 
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Fig. 9. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]). At baseline Bcl-2 concentration, each of the four mechanisms for Bcl-2 inhibition 
are similar. Both simulators agree across all rulesets: Bcl-2 binding with Bax only, Bid only, tBid 
only, or Bax and tBid. 
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Fig. 10. On the right is the Membrane System and on the left is the ODE simulation (used with 
permission [9]). Unlike the type II pathway, the type I pathway is unaffected by a 100-fold Bcl-2 
increase. The results of our simulations show that increasing Bcl-2 does not affect the type I 
pathway. 
6. Discussion And Final Remarks 
We have provided a discrete nondeterministic method for modeling molecular sig-
naling cascades, highlighting the changes from our previous technique. Using a 
small example signaling cascade, we were able to demonstrate the effectiveness of 
our simulator for modeling low molecular multiplicity systems. We also gave our 
results from simulating the Fas-mediated apoptotic pathway. 
Our Membrane System has yielded results comparable to an ordinary differen-
tial equations technique. The sixteen distinct simulations show similar apoptotic 
behavior to the ODE method (Fig. 4 - Fig. 10). However, albeit the activa-
tion of Caspase-3 is similar between the two techniques, the molecular interactions 
throughout are different. We have compared the results of our simulator with the 
experimental results the ODE results from the same paper, and the stochastic 
approach described The Caspase-3 results are as expected, but the activation 
of Caspase-8 raises our interest. Refer to Fig. 11 for a comparison. 
The consistency between the framework and the experimental results of 
validates our model. Our Nondeterministic Waiting Time algorithm shows that 
Membrane Systems are an intriguing alternative to ordinary differential equations 
Time (Hour) Time (Hour) 
Fig. 11. The experimental data and ODE simulation results were obtained from Fei Hua et al. We 
see that the decrease of full length Caspase-3 is similar in all three simulation results. Interestingly, 
the decline of full length Caspase-8 is less prominent in the two Membrane System simulations. 
The contrast could be a result of the discrete nature of the Membrane Systems. As for both results 
being different than the experimental data, we believe that further investigation of kinetic rates 
of the reactions will allow for better agreement between simulation and experimentation. 
methods. We have argued that the discrete nature of our technique might be better 
for simulating the evolution of systems involving low numbers of molecules. In the 
future, we would like to add a stochastic element to the Nondeterministic Waiting 
Time algorithm by allowing the simulation module to choose stochastically between 
rules that are not tied. 
Another future thrust of our group will be the extension and refinement of 
the pathway discussed here. We plan to model the behavior of the caspase-based 
apoptotic pathway in HIV-infected cells. The few proteins encoded in HIV appear 
to have severe consequences on Fas-induced apoptosis The so-called 'latently' 
infected T cells are especially interesting in the eradication of the AIDS epidemic 
We will also be applying our model to signaling cascades other than the Fas-
mediated apoptotic pathway. In particular, we are interested in modeling oscillatory 
dynamics, such as the p53 digital response described in 
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